IPMN

11 registered clinical trials studyying IPMN — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Surveillance Discontinuation in 5 Year Stable Trivial Branch Duct Intraductal Papillary Mucinous Neoplasms NCT07056972	Azienda Ospedaliera di Padova	—
Not Yet Recruiting	Impact of GLP-1 Receptor Agonists on Patients With IPMN NCT07014709	Hôpital Fribourgeois	—
Recruiting	Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer NCT05117723	St Vincent's Hospital Melbourne	—
Unknown	Pancreatic Cancer and Oral Microbiome NCT04993846	Azienda Ospedaliera Universitaria Integrata Verona	—
Active Not Recruiting	The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) NCT04207944	Duke University	Phase 2
Completed	Utility of EUS-guided Microbiopsies in Pancreatic Cystic Lesions NCT03578445	Herlev Hospital	N/A
Unknown	Quality of Life Assessment in Patients Who Are Under Surveillance for IPMN NCT03131076	Helsinki University Central Hospital	—
Active Not Recruiting	Feasibility of Molecular Biology in Pancreatic Cyst Tumors NCT03305146	Hospital St. Joseph, Marseille, France	N/A
Suspended	Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study NCT04306939	University of Pittsburgh	—
Completed	TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer NCT03914950	Medical University of Graz	N/A
Terminated	Intraductal Papillary Mucinous Neoplasm With Malignant Change NCT02044926	Asan Medical Center	—